Sichuang Yihui's latest claim news:
On April 25, 2024, Xie Baoping's financial and securities team submitted a batch of new materials to the Intermediate People's Court of Hangzhou Municipality, Zhejiang Province, for the filing of claims by 300078 Sichuang Medical Benefit Investors. These investors were sent to the dock to demand compensation for the losses caused by the previous violations of laws and regulations.
Prior to this, on January 8, 2024, the company received the "Administrative Penalty Decision" ([2023] No. 49) and the "Market Ban Decision" ([2023] No. 5) issued by the Zhejiang Supervision Bureau of the China Securities Regulatory Commission.
After investigation, Sichuang Yihui and Zhang Li have the following illegal facts:
1. The public offering documents of Sichuang Yihui fabricated material false content
(1) Public issuance of Sichuang Medical Benefits:
On January 22, 2021, Sichuang Yihui publicly disclosed the "Prospectus", which contains its financial data for 2017, 2018, 2019 and 2020 from January to September. On February 1, 2021, Sichuang Yihui disclosed the "Announcement on the Issuance Results of Convertible Corporate Bonds to Unspecified Objects", stating that the scale of convertible bonds issued this time was 81,700.00 yuan.
(2) The public offering documents of Sichuang Yihui fabricated material false content:
Through its wholly-owned subsidiary, Yihui Technology Co., Ltd. (hereinafter referred to as Yihui Technology), Hangzhou Wenran Information Technology Co., Ltd. (hereinafter referred to as Hangzhou Wenran), Shanghai Xifan Technology Service Co., Ltd. (hereinafter referred to as Shanghai Xifan), and Shenzhen Yulin Technology Service Co., Ltd. (hereinafter referred to as Shenzhen Yulin) carried out false business, and the cumulative inflated operating income in 2019 was 34,929,355.97 yuan, and the inflated profit was 33. 021,672.43 yuan, accounting for 20.03% of the total profit of the current period.
2. There are false records in the 2019 and 2020 annual reports of Sichuang Yihui:
In 2019, Sichuang Yihui carried out false business with Hangzhou Wenran, Shanghai Xifan and Shenzhen Yulin, etc., and the cumulative inflated operating income was 34,929,355.97 yuan and the inflated profit was 33,021,672.43 yuan, accounting for 20.03% of the total profit for the current period. The corresponding financial data in the 2019 Annual Report of Sichuang Yihui was not truthfully disclosed.
Through its wholly-owned subsidiary, Yihui Technology, Hangzhou Wenran, Shanghai Xifan, Shenzhen Yulin, Hangzhou Kaitai New Health Technology Co., Ltd. (hereinafter referred to as Kaitaixin) and Yixin Huitong carried out false business, as well as confirmed the income and cost of related businesses with Guangdong Huashang and Henan Eton in advance, the cumulative inflated operating income in 2020 was 96,468,786.13 yuan, the cumulative inflated cost was 9,228,186.66 yuan, and the inflated profit was 83. 941,383.25 yuan, accounting for 67% of the total profit for the period. The corresponding financial data in the 2020 annual report of Sichuang Yihui were not truthfully disclosed.
The above-mentioned illegal facts are supported by evidence such as the relevant public offering documents and periodic reports, meeting resolutions, financial information, business contracts, explanations, bank account information, explanations and materials provided by relevant customers and personnel, verification and analysis reports provided by accounting firms, and records of inquiries by relevant personnel, which are sufficient to determine. The CSRC believes that the fabrication of material false content in the above-mentioned public offering documents violates the Administrative Measures for the Issuance and Trading of Corporate Bonds (Decree No. 113 of the CSRC).
Based on the illegal disclosure of Sichuang Yihui's information, as well as the facts, nature, circumstances and degree of social harm of the parties' illegal acts, the CSRC intends to decide: 1. Order Sichuang Yihui Technology Co., Ltd. to make corrections, give a warning, and impose a fine of 85.7 million yuan; 2. Zhang Lizhong was given a warning and fined 7.5 million yuan.
According to the Securities Law and the Several Provisions of the Supreme People's Court on the Trial of Civil Compensation Cases Arising from False Statements in the Securities Market, listed companies shall be liable for civil compensation if their rights and interests are damaged due to illegal information disclosure and misrepresentation, and the injured investors have the right to claim compensation for losses.
The reference conditions for the claim are as follows:
Those who bought 300078 Smartrac Medical Benefit between April 30, 2020 and October 28, 2022, and sold or continued to hold it after October 29, 2022 (inclusive).
The above claim registration conditions only represent the views of Xie Baoping's lawyer team, and are not used as any securities investment decisions and trading suggestions, and are subject to the final determination of the court.
Basis for the violation:
On October 28, 2022, Sichuang Yihui received the Notice of Case Filing issued by the China Securities Regulatory Commission.
On September 25, 2023, Sichuang Yihui received the "Prior Notice of Administrative Punishment and Market Ban" issued by the Zhejiang Supervision Bureau of the China Securities Regulatory Commission.
On January 8, 2024, Sichuang Yihui received the Administrative Penalty Decision ([2023] No. 49) and the Market Prohibition Decision ([2023] No. 5) issued by the Zhejiang Supervision Bureau of the China Securities Regulatory Commission.